Skip to content

Stereotactic Hypofractionated Radiosurgery for Early Stage Prostate Cancer

Phase 1 Study of Stereotactic Hypofractionated Radiosurgery of Low Grade Prostate Cancer/Early Stage

Status
UNKNOWN
Phases
Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00969202
Enrollment
50
Registered
2009-09-01
Start date
2009-08-31
Completion date
2016-12-31
Last updated
2015-11-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostate Cancer

Keywords

Prostate Cancer, Cancer of the Prostate, Prostate Tumor, Novalis Tx, Novalis, Stereotactic Radiosurgery, Radiosurgery, Radiation

Brief summary

The purpose of this trial is to evaluate a short course of very focused (stereotactic) external beam radiation therapy for the treatment of early stage prostate cancer. The investigators will gather scientific information about the tolerance and side effects this type of radiation. The investigators will then compare these results with those of standard 8 week course of external beam radiation therapy to see if this study treatment is equally or more effective in treating prostate cancer.

Interventions

RADIATIONStereotactic Radiosurgery using the Novalis Tx

Five treatments given every other day.

Sponsors

San Diego Radiosurgery
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
MALE
Age
18 Years to 99 Years
Healthy volunteers
No

Inclusion criteria

* Histologically confirmed adenocarcinoma of the prostate * Gleason score ≤ 6 and low volume Gleason 7 (3+4) * PSA \< 10 * Clinical Stage of T2a or less * Ability to understand and the willingness to sign a written informed consent document

Exclusion criteria

* Prior radiation treatment for prostate cancer * Gleason score \> 7 * PSA \> 10 * Clinical Stage of T2b or greater

Design outcomes

Primary

MeasureTime frame
PSA decline measured through laboratory testing.One month following radiosurgery through 5 year follow up

Secondary

MeasureTime frame
Quality of life in relation to urinary, bowel and sexual function. Measured through a questionnaire at each follow up visit.One month following radiosurgery through 5 years follow up.

Countries

United States

Contacts

Primary ContactJennifer Joiner
Jennifer.joiner@palomarhealth.org760-739-3185
Backup ContactJeremy Legg
jlegg@Allianceoncology.com615-920-1282

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026